Robust and cost-effective CRISPR/Cas9 gene editing of primary tumor B cells in Eµ-TCL1 model of chronic lymphocytic leukemia.
Rosita Del PreteRoberta DragoFederica NardiGaia BartoliniErika BelliniAntonella De RosaSilvia ValensinAnna KabanovaPublished in: HemaSphere (2024)